MedNation AG (FRA:EIF) Moat Score: 0/10 (As of Jul. 04, 2026)


FRA:EIF MedNation AG FRA:EIF
67 GF Score
Price €4.30
GF Value €2.35
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is MedNation AG Moat Score?

MedNation AG has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

MedNation AG has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes MedNation AG might have No Moat - No discernible moat.


MedNation AG  (FRA:EIF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

MedNation AG Moat Score Related Terms

FRA:EIF
67GF Score
MedNation AG FRA:EIF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MedNation AG (FRA:EIF) Overvalued in 2026?

Based on GuruFocus' analysis, MedNation AG stock appears to be overvalued. The current stock price of €4.30 is trading 83% above its estimated GF Value™ of €2.35. GuruFocus considers MedNation AG to be Significantly Overvalued.

Key valuation signals for FRA:EIF:

  • Moat Score: 0
  • GF Value™: €2.35 vs. price of €4.30 (83% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the FRA:EIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedNation AG Business Description

Other Exchanges EIF:Germany
Address Graurheindorfer Strasse 137, Bonn, NW, DEU, 53117
MedNation AG operates rehabilitation hospitals. It has been operating facilities for rehabilitation, geriatric care and outpatient medical care at several locations for decades. The business purpose of MedNation AG also includes the development of independent outpatient centers as central, multidisciplinary medical centers to support freelance KV outpatient, specialist and medical-related care, especially in rural regions of Germany.
67GF Score

Get the complete analysis for FRA:EIF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.30
Price
€2.35
GF Value